About Me
Dr. Brandon Bentzley, M.D., Ph.D., is a psychiatrist and neuroscientist focused on advancing precision neuromodulation therapies for severe, treatment-resistant neuropsychiatric conditions. His work centers on developing rapid-acting, personalized treatments that bridge clinical research, translational neuroscience, and real-world care delivery. As Director of Innovation at the Stanford Brain Stimulation Lab, he collaborated with Dr. Nolan Williams to develop SAINT® (Stanford Accelerated Intelligent Neuromodulation Therapy), an FDA-cleared, non-invasive treatment for treatment-resistant depression and the first to use functional connectivity MRI guidance. In 2020, he co-founded Magnus Medical to support SAINT’s clinical adoption, and in 2024, co-founded Salma Health to advance next-generation brain health treatments. Dr. Bentzley completed his M.D. and Ph.D. at MUSC and trained at Stanford. He has published extensively in leading peer-reviewed journals.